Chemed Co. (NYSE:CHE) Shares Acquired by Keeley Teton Advisors LLC

Keeley Teton Advisors LLC grew its stake in Chemed Co. (NYSE:CHE - Free Report) by 9.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,231 shares of the company's stock after buying an additional 611 shares during the period. Keeley Teton Advisors LLC's holdings in Chemed were worth $3,831,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. UMB Bank n.a. lifted its holdings in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Atala Financial Inc purchased a new position in shares of Chemed during the fourth quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares during the period. Trust Co. of Vermont purchased a new stake in Chemed in the 4th quarter valued at $34,000. Finally, Tortoise Investment Management LLC boosted its stake in Chemed by 77.3% during the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after purchasing an additional 34 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on CHE. Royal Bank of Canada increased their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Trading Down 0.1 %

Shares of Chemed stock traded down $0.86 on Friday, reaching $580.52. 110,655 shares of the stock were exchanged, compared to its average volume of 97,899. The firm has a market capitalization of $8.48 billion, a PE ratio of 29.33, a PEG ratio of 2.15 and a beta of 0.49. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $623.61. The business has a fifty day moving average price of $585.78 and a two-hundred day moving average price of $567.83.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed's dividend payout ratio (DPR) is presently 10.05%.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 3.32% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.